This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.  Read our Cookies Policy.
Close
Eye News
  • Features
    • Close
    • Features
    • Allied Professions
    • Humanitarian
    • Interviews
    • AI & Oculomics
    • Ophthalmology
    • Optometry
    • Podcast videos
    • Supplements
  • Education
    • Close
    • Education
    • Learning Curve
    • Quiz
    • Top Tips
    • Trainees
    • Medico-Legal
    • The Truth Behind The Headlines
    • Case Reports
    • Pete's Bogus Journey
  • Reviews
    • Close
    • Reviews
    • Book Reviews
    • Journal Reviews
    • What's trending?
    • Tech Reviews
    • My Top Five
    • The Culture Section
  • Events
  • News
  • Product Guide
  • Industry News
  • Contact us
    • Close
    • Contact us
    • Write for Eye News
  • Home
  • Reviews
  • Journal Reviews
  • Children’s perspectives of amblyopia treatment

Children’s perspectives of amblyopia treatment
Reviewed by Fiona Rowe

5 June 2020 | Fiona Rowe (Prof) | EYE - Paediatrics, EYE - Strabismus
Share This

This study measured the impact of amblyopia treatment (patching and atropine) on health-related quality of life from the child’s perspective using the Child Amblyopia Treatment Quality of Life (CATQoL) questionnaire. The study recruited 46 children with no treatment in the two-month period prior to study enrolment. Two groups consisted of patching (61%) versus atropine (39%). The atropine group had children with poorer visual acuity. Age was similar across both groups. Children also completed the PEDSQL questionnaire – the scores of this questionnaire did not change significantly after four weeks of treatment. The same occurred for the CATQoL scores. Parents and children chose their treatment options and the findings suggest that offering this choice as the first-line treatment for amblyopia is appropriate, as children tolerated both equally well.

Amblyopia treatment and quality of life; the child’s perspective on atropine versus patching.
Steel DA, Codina CJ, Arblaster GE.
STRABISMUS
2019;27(3):156-64.
Share This
Fiona Rowe (Prof)
CONTRIBUTOR
Fiona Rowe (Prof)

Institute of Population Health, University of Liverpool, UK.

View Full Profile
Specialty
  • EYE - Cataract
  • EYE - Cornea
  • EYE - General
  • EYE - Glaucoma
  • EYE - Neuro-ophthalmology
  • EYE - Oculoplastic
  • EYE - Oncology
  • EYE - Orbit
  • EYE - Paediatrics
  • EYE - Pathology
  • EYE - Refractive
  • EYE - Strabismus
  • EYE - Vitreo-Retinal
Archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013

Top Of Page

9 Gayfield Square, 
Edinburgh EH1 3NT, UK.

Call: +44 (0)131 557 4184
www.pinpoint-scotland.com

WEBSITE DETAILS
  • Cookie Policy
  • Data Protection Notice
  • Privacy Policy
  • Terms and Conditions
ABOUT US
  • Who we are
  • Register
  • Contact us
  • Contributors
  • Company Awards
DIGITAL ISSUES/GUIDELINES
  • Digital issues - Library
  • Supplements - Library
  • Guidelines
Accreditations
IPSO_FLAG_TEAL 2025.png cpdcertified.png

Pinpoint Scotland Ltd (Registered in Scotland No. SC068684) | © 2025 - Website by Gecko Agency